SUBSCRIBERS
US firms selling unapproved 'stem cell treatments'
Published Fri, Jul 1, 2016 · 09:50 PM
Miami
HUNDREDS of companies across the United States are selling unapproved stem cell treatments directly to patients, raising concerns about safety and scams in a fast-growing industry, researchers said on Thursday.
At least 351 companies across the United States are marketing unapproved stem cell procedures at 570 individual clinics, the researchers' report in the journal Cell Stem Cell found.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue